Gene Sequencing – to the Bedside
Reporter: Larry H Bernstein, MD, FCAP
Gene sequencing leaves the laboratory
Maturing technology speeds medical diagnoses.
Erika Check Hayden 19 February 2013
The steep fall in the cost of sequencing a genome has, for the moment, slowed. Yet researchers attending this year’s Advances in Genome Biology and Technology (AGBT) meeting in Marco Island, Florida, on 20–23 February are not complaining. At a cost as low as US$5,000–10,000 per human genome, sequencing has become cheap and reliable enough that researchers are not waiting for the next sequencing machine to perfect new applications in medicine.
Single-cell genomics is allowing fertility clinics to screen embryos for abnormalities more cheaply.
Human genome to genes (Photo credit: Wikipedia)
Related articles
- Genome sequencing of the Healthy (pharmaceuticalintelligence.com)
- 2013 Genomics: The Era Beyond the Sequencing Human Genome: Francis Collins, Craig Venter, Eric Lander, et al. (pharmaceuticalintelligence.com)
- Gene sequencing leaves the laboratory (nature.com)
- Real Time Genomics Announces Platform Launch, Expanding Commercial Operations (prweb.com)
- Solid-State Sequencer Debuts at Genome Conference (technologyreview.com)
- Research and Markets: DNA Sequencing – Technologies, Markets and Companies – 2013 (prweb.com)
2012pharmaceutical
sjwilliamspa